Prothena Corp Public (PRTA) Accounts Payables (2013 - 2026)
Prothena Corp Public's (PRTA) quarterly Accounts Payables came in at $4.3 million in Q1 2026, down 73.18% year-on-year from $16.0 million in Q1 2025, and down 26.83% quarter-over-quarter from $5.9 million in Q4 2025.
Prothena Corp Public (PRTA) Accounts Payables (2013 - 2026) Analysis & Trends
Prothena Corp Public's Accounts Payables history runs 14 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- On a quarterly basis, Accounts Payables fell 73.18% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 73.18% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 24.39% from the prior year.
- Accounts Payables retreated to $4.3 million in Q1 2026 per PRTA's latest filing, from $5.9 million in the prior quarter.
- Across five years, Accounts Payables topped out at $25.4 million in Q4 2023 and bottomed at $4.3 million in Q1 2026.
- The 5-year median for Accounts Payables is $10.3 million (2024), against an average of $11.6 million.
- Across the five-year window, Accounts Payables jumped 181.02% in 2022 and tumbled 73.18% in 2026, its largest moves.
- Year by year, Accounts Payables stood at $9.3 million in 2022, then jumped by 173.91% to $25.4 million in 2023, then tumbled by 69.4% to $7.8 million in 2024, then retreated by 24.39% to $5.9 million in 2025, then dropped by 26.83% to $4.3 million in 2026.
- Per Business Quant, the three latest PRTA Accounts Payables figures stand at $4.3 million (Q1 2026), $5.9 million (Q4 2025), and $10.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 5.88 Mn |
| Sep 30, 2025 | 10.50 Mn |
| Jun 30, 2025 | 12.20 Mn |
| Mar 31, 2025 | 16.03 Mn |
| Dec 31, 2024 | 7.77 Mn |
| Sep 30, 2024 | 10.33 Mn |
| Jun 30, 2024 | 9.29 Mn |
| Mar 31, 2024 | 14.42 Mn |
| Dec 31, 2023 | 25.39 Mn |
| Sep 30, 2023 | 19.46 Mn |
| Jun 30, 2023 | 13.85 Mn |
| Mar 31, 2023 | 12.52 Mn |
| Dec 31, 2022 | 9.27 Mn |
| Sep 30, 2022 | 9.79 Mn |
| Jun 30, 2022 | 7.55 Mn |
| Mar 31, 2022 | 9.32 Mn |
| Dec 31, 2021 | 3.69 Mn |
| Sep 30, 2021 | 3.48 Mn |
| Jun 30, 2021 | 5.91 Mn |